These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
392 related items for PubMed ID: 2221864
1. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers. Appelbaum PC, Spangler SK, Jacobs MR. Antimicrob Agents Chemother; 1990 Aug; 34(8):1546-50. PubMed ID: 2221864 [Abstract] [Full Text] [Related]
2. Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole. Jacobs MR, Spangler SK, Appelbaum PC. Eur J Clin Microbiol Infect Dis; 1990 Jun; 9(6):417-21. PubMed ID: 2387295 [Abstract] [Full Text] [Related]
3. beta-Lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents. Jacobs MR, Spangler SK, Appelbaum PC. Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1081-93. PubMed ID: 1295763 [Abstract] [Full Text] [Related]
4. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres. Jacobs MR, Spangler SK, Appelbaum PC. J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827 [Abstract] [Full Text] [Related]
5. Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents. Appelbaum PC, Spangler SK, Jacobs MR. Antimicrob Agents Chemother; 1991 Jun; 35(6):1214-8. PubMed ID: 1929264 [Abstract] [Full Text] [Related]
6. Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group. Stratton CW, Weeks LS, Aldridge KE. Diagn Microbiol Infect Dis; 1992 Jun; 15(4):321-30. PubMed ID: 1611847 [Abstract] [Full Text] [Related]
7. Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents. Downes J, Andrew JH. Pathology; 1988 Jul; 20(3):260-3. PubMed ID: 3205597 [Abstract] [Full Text] [Related]
8. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group. Bourgault AM, Lamothe F. J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324 [Abstract] [Full Text] [Related]
9. Cross-resistance to beta-lactam-beta-lactamase inhibitor combinations and clindamycin among cefoxitin-resistant and cefoxitin-susceptible strains of the Bacteroides fragilis group. Aldridge KE. Diagn Microbiol Infect Dis; 1993 Oct; 17(3):251-6. PubMed ID: 8112038 [Abstract] [Full Text] [Related]
10. Role of Bacteroides bivius beta-lactamase in beta-lactam susceptibility. Lacroix JM, Lamothe F, Malouin F. Antimicrob Agents Chemother; 1984 Nov; 26(5):694-8. PubMed ID: 6335019 [Abstract] [Full Text] [Related]
11. Beta-lactamase activity of anaerobic bacteroides strains isolated from clinical samples and their susceptibility to antimicrobial agents. Uraz G, Türkmen L. Drug Metabol Drug Interact; 1999 Nov; 15(2-3):181-6. PubMed ID: 10707123 [Abstract] [Full Text] [Related]
12. In vitro activity of amoxycillin/clavulanate and ticarcillin/clavulanate compared with that of other antibiotics against anaerobic bacteria: comparison with the results of the 1987 survey. Pierard D, De Meyer A, Rosseel P, Van Cauwenbergh M, Struelens MJ, Delmee M, Goossens H, Claeys G, Glupczynski Y, Verbist L, Melin P, Lauwers S. Acta Clin Belg; 1996 Nov; 51(2):70-9. PubMed ID: 8693871 [Abstract] [Full Text] [Related]
13. Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents. Lachance N, Gaudreau C, Lamothe F, Turgeon F. Antimicrob Agents Chemother; 1993 May; 37(5):1174-6. PubMed ID: 8390812 [Abstract] [Full Text] [Related]
14. In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents. Betriu C, Sánchez A, Gómez M, Palau ML, Picazo JJ. J Antimicrob Chemother; 1999 Jan; 43(1):133-6. PubMed ID: 10381111 [Abstract] [Full Text] [Related]
15. Susceptibility of clinical isolates of Bacteroides fragilis group strains to cefoxitin, cefoperazone and ticarcillin/clavulanate. Peixoto Júnior AA, Rocha MM, Moreira JL, Carvalho CB. Rev Inst Med Trop Sao Paulo; 2000 Jan; 42(3):137-9. PubMed ID: 10887372 [Abstract] [Full Text] [Related]
16. Evaluation of antibiotic susceptibility of Bacteroides, Prevotella and Fusobacterium species isolated from patients of the N. N. Blokhin Cancer Research Center, Moscow, Russia. Shilnikova II, Dmitrieva NV. Anaerobe; 2015 Feb; 31():15-8. PubMed ID: 25157873 [Abstract] [Full Text] [Related]
17. Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin. Pankuch GA, Jacobs MR, Appelbaum PC. Antimicrob Agents Chemother; 1993 Aug; 37(8):1649-54. PubMed ID: 8215278 [Abstract] [Full Text] [Related]
18. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms. Hsueh PR, Chang SC, Chen YC, Hsu LY, Luh KT, Hsieh WC. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000 [Abstract] [Full Text] [Related]
19. Imipenem resistance in Bacteroides distasonis mediated by a novel beta-lactamase. Hurlbut S, Cuchural GJ, Tally FP. Antimicrob Agents Chemother; 1990 Jan; 34(1):117-20. PubMed ID: 2327745 [Abstract] [Full Text] [Related]
20. In vitro activities of antibacterial agents against clinical isolates of Escherichia coli and Klebsiella species from intensive care units. Gill CJ, Ponticas S, Shungu DL, Guerriero S. Clin Ther; 1991 Jan; 13(1):25-37. PubMed ID: 2029725 [Abstract] [Full Text] [Related] Page: [Next] [New Search]